EPITOPE INC/OR/
8-K, 1997-04-03
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: HARMAN INTERNATIONAL INDUSTRIES INC /DE/, 8-K, 1997-04-03
Next: ADVO INC, SC 13D, 1997-04-03



                      SECURITIES AND EXCHANGE COMMISSION

                            Washington, D.C.  20549

                               -----------------

                                   FORM 8-K

                                CURRENT REPORT

                      Pursuant to Section 13 or 15(d) of
                      the Securities Exchange Act of 1934

               Date of Report (Date of earliest event reported):

                                 April 1, 1997

                               -----------------


                                 EPITOPE, INC.
              (Exact name of Registrant as specified in charter)

                                    Oregon
                (State or other jurisdiction of incorporation)

                                    1-10492
                             (Commission File No.)

                                  93-0779127
                       (IRS Employer Identification No.)

                            8505 S.W. Creekside Place
                             Beaverton, Oregon 97008
              (Address of principal executive offices) (Zip Code)

               Registrant's telephone number, including area code:

                                 (503) 641-6115




<PAGE>


Item 5.     Other Events.

            On  April  1 and 2,  1997,  Epitope,  Inc.,  issued  press  releases
regarding a recall of  strawberries  by its Andrew and  Williamson  Sales,  Co.,
subsidiary.  Copies of the press  releases  are  attached  as  exhibits  to this
report.

Item 7.     Financial Statements, Pro Forma Financial Information and Exhibits.

            (a)   Not applicable.

            (b)   Not applicable.

            (c)   Exhibits.

            The  exhibits  to  this  report  are  listed  in the  exhibit  index
following the signature page.




<PAGE>



                                  SIGNATURES

            Pursuant to the requirements of the Securities Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                  EPITOPE, INC.


Dated:  April 2, 1997       By: /s/ Gilbert N. Miller
                                Gilbert N. Miller
                                Executive Vice President and Chief
                                Financial Officer



<PAGE>


                                  EXHIBIT INDEX


99.1  Press release of Epitope, Inc., dated April 1, 1997.

99.2  Press release of Epitope, Inc., dated April 2, 1997.



                                  Exhibit 99.1

FOR IMMEDIATE RELEASE                                   Contact:    Mary Hagen
                                                                  503.641.6115



           Andrew and Williamson Initiates Voluntary Product Recall

Beaverton,  Oregon, April 1 -- Epitope, Inc.  (NASDAQ:EPTO) today announced that
Andrew and Williamson Sales Co., its recently  acquired wholly owned subsidiary,
has commenced a voluntary recall of thirteen lots of frozen, sliced strawberries
shipped to distributors for  institutional  use in six states.  The berries have
been associated with an occurrence of Hepatitis A in several  Michigan  schools.
Hepatitis A is a flu-like,  temporary  illness.  The lots  subject to the recall
were shipped early in December 1996,  shortly  before Epitope  acquired A&W. The
berries were grown in Mexico and processed in San Diego.

"The health and well-being of the public is A&W's foremost concern.  While it is
not certain that the lots being recalled are contaminated,  we want to eliminate
all possible  risk to consumers.  Therefore,  we have notified our customers who
received the shipments in question and requested  that they remove them from the
market," said Adolph J. Ferro, president and chief executive officer of Epitope.
"We are  cooperating  fully  with  both the  Centers  for  Disease  Control  and
Prevention and the U.S. Food and Drug Administration, who are assisting with the
recall process."

Hepatitis A is usually a mild and  self-limiting  illness.  Symptoms may include
malaise,  nausea,  fatigue, loss of appetite, low grade fever and jaundice. Some
patients, particularly young children, experience no symptoms at all.

                                      ###



                                  Exhibit 99.2

FOR IMMEDIATE RELEASE                                   Contact:    Mary Hagen
                                                                  503.641.6115



   Epitope Announces Further Developments with Regard to Hepatitis A Outbreak

Beaverton,  Oregon,  April 2 --  Epitope,  Inc.  (NASDAQ:EPTO)  today  announced
further  developments  regarding  a recall of  strawberries  by its  subsidiary,
Andrew and Williamson  Sales Co.,  following a Hepatitis A outbreak in Michigan.
The company has learned that A&W inaccurately described some of the strawberries
associated  with the outbreak as having been grown and  processed in the U.S. as
required by the U.S.  Department of Agriculture  School Lunch Program.  In fact,
the  berries  were grown in Mexico and  processed  in the U.S.  This  inaccurate
description occurred prior to the acquisition of A&W by Epitope.

"We have  notified  the USDA of our concern  with regard to this matter and have
today accepted the  resignation of Fred L.  Williamson,  the president and chief
executive  officer of A&W," said Adolph J. Ferro,  president and chief executive
officer of  Epitope.  "As the health and  well-being  of the public  remains our
foremost  concern,  we will  continue  to  work  with  appropriate  governmental
agencies."

Hepatitis A is usually a mild and  self-limiting  illness.  Symptoms may include
malaise,  nausea,  fatigue, loss of appetite, low grade fever and jaundice. Many
people  infected with Hepatitis A may have no symptoms or may have mild symptoms
without jaundice.

                                      ###



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission